Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms. [electronic resource]
Producer: 20130328Description: 269-83 p. digitalISSN:- 1179-2000
- Adaptor Proteins, Signal Transducing
- Alleles
- Benzamides -- therapeutic use
- Bridged-Ring Compounds -- therapeutic use
- Carbazoles -- therapeutic use
- Chromatin -- genetics
- DNA (Cytosine-5-)-Methyltransferases -- genetics
- DNA Methyltransferase 3A
- DNA-Binding Proteins -- genetics
- Dioxygenases
- Enhancer of Zeste Homolog 2 Protein
- Epigenesis, Genetic
- Furans
- Gene Expression Regulation
- Humans
- Ikaros Transcription Factor -- genetics
- Intracellular Signaling Peptides and Proteins
- Isocitrate Dehydrogenase -- genetics
- Janus Kinase 2 -- antagonists & inhibitors
- Mutation
- Myeloproliferative Disorders -- genetics
- Nitriles
- Polycomb Repressive Complex 2 -- genetics
- Proteins -- genetics
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins c-cbl -- genetics
- Pyrazoles -- therapeutic use
- Pyrimidines -- therapeutic use
- Pyrrolidines -- therapeutic use
- Receptors, Thrombopoietin -- genetics
- Repressor Proteins -- genetics
- Signal Transduction
- Spliceosomes -- metabolism
- Sulfonamides -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.